Rebel Medicine Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$8.79M
- Investors
-
11
Rebel Medicine General Information
Description
Developer of a non-opioid pharmaceutical product pipeline designed to address acute pain management in postoperative clinical settings. The company focuses on the research and development of long-acting local anesthetic drug candidates for post-surgical pain relief, with a pipeline centered on formulations that aim to provide extended-duration analgesic effects without the use of opioid compounds, supported by ongoing regulatory advancement and clinical development activities, enabling hospitals, surgical centers, and healthcare providers to offer patients non-addictive, long-acting pain management alternatives in the postoperative recovery period.
Contact Information
Website
www.rebelmedicine.comCorporate Office
- 48 South Rio Grande Street
- Salt Lake City, UT 84101
- United States
Corporate Office
- 48 South Rio Grande Street
- Salt Lake City, UT 84101
- United States
Rebel Medicine Timeline
Rebel Medicine Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series A) | 03-Jun-2026 | $8.79M | Completed | Pre-Clinical Trials | ||
| 6. Grant | 30-Sep-2024 | Completed | Pre-Clinical Trials | |||
| 5. Grant | 30-Sep-2023 | Completed | Pre-Clinical Trials | |||
| 4. Seed Round | 22-Dec-2021 | Completed | Pre-Clinical Trials | |||
| 3. Grant | 30-Sep-2021 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | 01-Dec-2020 | Completed | Pre-Clinical Trials | |||
| 1. Grant | 01-Jan-2020 | $256K | Completed | Pre-Clinical Trials |
Rebel Medicine Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed 1 | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Rebel Medicine Comparisons
Industry
Financing
Details
Rebel Medicine Competitors (4)
One of Rebel Medicine’s 4 competitors is AmacaThera, a Venture Capital-Backed company based in Toronto, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AmacaThera | Venture Capital-Backed | Toronto, Canada | ||||
| Pacira BioSciences | Formerly VC-backed | Tampa, FL | ||||
| Heron Therapeutics | Formerly VC-backed | Cary, NC | ||||
| PRF Technologies | Formerly VC-backed | Tel Aviv, Israel |
Rebel Medicine Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Rebel Medicine Patents
Rebel Medicine Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025212904-A1 | Pharmaceutical oil-in-water emulsion for treating pain | Pending | 05-Apr-2024 | ||
| WO-2025015222-A2 | Pharmaceutical compositions | Inactive | 12-Jul-2023 | ||
| WO-2025015222-A3 | Pharmaceutical compositions | Inactive | 12-Jul-2023 | ||
| WO-2023230509-A2 | Extended-release composite wound dressing | Inactive | 24-May-2022 | ||
| WO-2023230509-A3 | Extended-release composite wound dressing | Inactive | 24-May-2022 | A61K31/445 |
Rebel Medicine Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Rebel Medicine Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cantina Angels | Angel Group | Minority | ||
| Central Texas Angel Network | Angel Group | Minority | ||
| Crocker Ventures | Venture Capital | Minority | ||
| Joan and Tim Fenton Founders Fund | Venture Capital | Minority | ||
| prosperity solutions | Corporation | Minority |
Rebel Medicine FAQs
-
When was Rebel Medicine founded?
Rebel Medicine was founded in 2020.
-
Where is Rebel Medicine headquartered?
Rebel Medicine is headquartered in Salt Lake City, UT.
-
What is the size of Rebel Medicine?
Rebel Medicine has 13 total employees.
-
What industry is Rebel Medicine in?
Rebel Medicine’s primary industry is Drug Discovery.
-
Is Rebel Medicine a private or public company?
Rebel Medicine is a Private company.
-
What is Rebel Medicine’s current revenue?
The current revenue for Rebel Medicine is .
-
How much funding has Rebel Medicine raised over time?
Rebel Medicine has raised $11.8M.
-
Who are Rebel Medicine’s investors?
Cantina Angels, Central Texas Angel Network, Crocker Ventures, Joan and Tim Fenton Founders Fund, and prosperity solutions are 5 of 11 investors who have invested in Rebel Medicine.
-
Who are Rebel Medicine’s competitors?
AmacaThera, Pacira BioSciences, Heron Therapeutics, and PRF Technologies are competitors of Rebel Medicine.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
